STAA
Staar Surgical Co
stockNASDAQ
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 25.21 | 2026-11-06 | +4.68% | 0.976 |
| 1M | 21.50 | 2026-10-13 | +22.74% | 1.000 |
| 3M | 25.33 | 2026-08-13 | +4.18% | 0.573 |
| 6M | 29.40 | 2026-05-13 | -10.24% | 0.470 |
| 1Y | 26.03 | 2025-11-13 | +1.38% | 0.390 |
| 2Y | 28.44 | 2024-11-13 | -7.21% | — |
| 5Y | 113.38 | 2021-11-12 | -76.72% | 1.282 |
Staar Surgical Co (NASDAQ:STAA) stock price today is $26.39, and today's volume is 300,136. STAA is down 1.456% today. The 30 day average volume is 735,768. STAA market cap is $1.32B with 50.20M shares outstanding.